Temporary GMP Exemptions for Bacteriophage Therapies in Australia
Published on: 02/11/2025
The proposed temporary GMP exemption by the TGA for personalised bacteriophage therapy manufacture in Australia marks a significant regulatory development for the emerging phage‑therapy sector.
News



